CME Group (CME) reported $1.54 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3%. EPS of $2.68 for the same period compares to $2.68 a year ago.
The reported revenue represents a surprise of +0.81% over the Zacks Consensus Estimate of $1.53 billion. With the consensus EPS estimate being $2.63, the EPS surprise was +1.9%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average daily volume (including NYMEX and COMEX): 25.32 million versus 26.2 million estimated by five analysts on average.
- Average rate per contract - Interest rates (including NYMEX and COMEX): $0.49 compared to the $0.48 average estimate based on five analysts.
- Average rate per contract - Equity indexes (including NYMEX and COMEX): $0.65 compared to the $0.65 average estimate based on five analysts.
- Average rate per contract - Foreign exchange (including NYMEX and COMEX): $0.84 versus the five-analyst average estimate of $0.79.
- Average rate per contract - Energy (including NYMEX and COMEX): $1.21 versus $1.19 estimated by five analysts on average.
- Average rate per contract - Agricultural commodities (including NYMEX and COMEX): $1.42 versus the five-analyst average estimate of $1.40.
- Average daily volume - Metals (including NYMEX and COMEX): 825 thousand compared to the 843.54 thousand average estimate based on five analysts.
- Average rate per contract (including NYMEX and COMEX): $0.70 versus the five-analyst average estimate of $0.69.
- Average daily volume - Interest rates (including NYMEX and COMEX): 13.38 million versus the five-analyst average estimate of 13.71 million.
- Revenues- Clearing and transaction fees: $1.23 billion versus the six-analyst average estimate of $1.25 billion. The reported number represents a year-over-year change of -5.3%.
- Revenues- Other: $107.2 million versus the six-analyst average estimate of $110.22 million. The reported number represents a year-over-year change of -1.7%.
- Revenues- Market data and information services: $202.5 million versus the six-analyst average estimate of $195.57 million. The reported number represents a year-over-year change of +13.6%.
View all Key Company Metrics for CME here>>>
Shares of CME have returned +2.5% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CME Group Inc. (CME): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
